Calian Group Ltd. (TSE:CGY - Get Free Report) reached a new 52-week high during trading on Monday . The company traded as high as C$53.65 and last traded at C$53.41, with a volume of 12031 shares trading hands. The stock had previously closed at C$52.55.
Analyst Upgrades and Downgrades
A number of research firms recently issued reports on CGY. Desjardins lowered their target price on shares of Calian Group from C$62.00 to C$59.00 and set a "buy" rating for the company in a report on Thursday, August 14th. Ventum Financial decreased their price target on shares of Calian Group from C$60.00 to C$58.00 and set a "buy" rating on the stock in a report on Thursday, August 14th. Finally, CIBC upped their price objective on Calian Group from C$50.00 to C$59.00 in a report on Monday, July 21st. Four investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus price target of C$60.67.
Read Our Latest Stock Analysis on CGY
Calian Group Price Performance
The business's 50 day moving average price is C$50.41 and its 200-day moving average price is C$47.42. The company has a quick ratio of 1.20, a current ratio of 1.29 and a debt-to-equity ratio of 39.54. The company has a market cap of C$605.82 million, a PE ratio of -890.00, a price-to-earnings-growth ratio of 2.50 and a beta of 0.44.
Calian Group Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Tuesday, September 9th. Shareholders of record on Tuesday, September 9th were issued a dividend of $0.28 per share. This represents a $1.12 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date of this dividend was Tuesday, August 26th. Calian Group's dividend payout ratio (DPR) is currently -1,866.67%.
Calian Group Company Profile
(
Get Free Report)
Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Calian Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calian Group wasn't on the list.
While Calian Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.